Clarithromycin-Induced Long QT Syndrome: A Case Report
Mecnun Çetin, Münevver Yıldırımer, Serkan Özen, Sema Tanrıverdi, Şenol Coşkun
Abstract
Open-access reader
Mecnun Çetin, Münevver Yıldırımer, Serkan Özen, Sema Tanrıverdi, Şenol Coşkun
Abstract
Open-access reader
Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia.
Key concepts: Clarithromycin, QT interval, Medicine, Pneumonia, Long QT syndrome, Antibiotics, Internal medicine, Microbiology